EDGAR Filing Documents for 0001213900-24-071491

Form 8-K - Current report:

SEC Accession No. 0001213900-24-071491

Filing Date

2024-08-21

Accepted

2024-08-21 16:45:57

Documents

Period of Report

2024-08-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea0211976-8k_silexion.htm	8-K	184941
2	PLAN OF MERGER FOR MERGER OF MORINGA ACQUISITION CORP AND MORINGA ACQUISITION ME	ea021197601ex2-2_silexion.htm	EX-2.2	29271
3	AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF SILEXION THERAPEU	ea021197601ex3-1_silexion.htm	EX-3.1	201132
4	ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT, DATED AS OF AUGUST 15, 2024, BY	ea021197601ex4-1_silexion.htm	EX-4.1	46399
5	FINAL INVOICE ISSUED BY EARLYBIRDCAPITAL, INC. TO MORINGA ACQUISITION CORP UNDER	ea021197601ex10-1i_silexion.htm	EX-10.1(1)	7810
6	CONVERTIBLE PROMISSORY NOTE, DATED AUGUST 15, 2024, IN AN AMOUNT OF $1,250,000,	ea021197601ex10-1ii_silexion.htm	EX-10.1(2)	26651
7	SUBSCRIPTION AGREEMENT, DATED AUGUST 15, 2024, BY AND AMONG MORINGA ACQUISITION	ea021197601ex10-2_silexion.htm	EX-10.2	172450
8	ORDINARY SHARE PURCHASE AGREEMENT, DATED AUGUST 13, 2024 AND EFFECTIVE AS OF THE	ea021197601ex10-3i_silexion.htm	EX-10.3(1)	220135
9	REGISTRATION RIGHTS AGREEMENT, DATED AUGUST 13, 2024 AND EFFECTIVE AS OF THE CLO	ea021197601ex10-3ii_silexion.htm	EX-10.3(2)	145144
10	AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT, DATED AUGUST 14,	ea021197601ex10-4_silexion.htm	EX-10.4	145896
11	AMENDED AND RESTATED PROMISSORY NOTE, DATED AUGUST 15, 2024, ISSUED BY SILEXION	ea021197601ex10-5_silexion.htm	EX-10.5	37569
12	FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT, DATED AUGUST 15, 2024, B	ea021197601ex10-6_silexion.htm	EX-10.6	103482
13	SILEXION THERAPEUTICS CORP 2024 EQUITY INCENTIVE PLAN	ea021197601ex10-12_silexion.htm	EX-10.12	206135
14	SILEXION THERAPEUTICS CORP CODE OF ETHICS AND BUSINESS CONDUCT	ea021197601ex14-1_silexion.htm	EX-14.1	40253
15	LIST OF SUBSIDIARIES	ea021197601ex21-1_silexion.htm	EX-21.1	2906
16	UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF SILEXION AS OF JUNE 30,	ea021197601ex99-1_silexion.htm	EX-99.1	482564
17	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AS O	ea021197601ex99-2_silexion.htm	EX-99.2	233257
18	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA	ea021197601ex99-3_silexion.htm	EX-99.3	113603
19	PRESS RELEASE, DATED AUGUST 15, 2024, ANNOUNCING THE CLOSING OF THE BUSINESS COM	ea021197601ex99-4_silexion.htm	EX-99.4	13611
	Complete submission text file	0001213900-24-071491.txt		2415335

Mailing Address 2 HAMAYAN STREET MODIIN-MACCABIM-REUT L3 7177871

Business Address 2 HAMAYAN STREET MODIIN-MACCABIM-REUT L3 7177871 972-8-6286005

Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)